Nolan Sean P. 4
4 · Taysha Gene Therapies, Inc. · Filed Jun 21, 2021
Insider Transaction Report
Form 4
Nolan Sean P.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2021-06-17+15,500→ 15,500 totalExercise: $25.04Exp: 2031-06-17→ Common Stock (15,500 underlying)
Footnotes (1)
- [F1]The shares vest on the earlier of June 17, 2022 or the next annual stockholders meeting, subject to continued service as a director though the applicable vesting date.